About: Galápagos NV   Goto Sponge  NotDistinct  Permalink

An Entity of Type : schema:Organization, within Data Space : dbpedia.org associated with source document(s)

Galapagos NV is a Belgo-Dutch pharmaceutical research company which was founded in 1999. The company started as a joint venture between Crucell - a Leiden based biotech company - and Belgian Tibotec. Currently it has drugs under investigation against rheumatoid arthritis, crohn's disease, ulcerative colitis, psoriasis and systemic lupus erythematosus. The stocks are traded at Euronext Amsterdam and Euronext Brussels under ticker GLPG and at the U.S. OTC market under the ticker symbol GLPYY. The CEO is the Dutchman Onno van de Stolpe. The headquarters are located in Mechelen, Belgium. Also Galapagos holds branches in Leiden, Romainville (France) and Zagreb (Croatia).

AttributesValues
rdf:type
rdfs:label
  • Galápagos NV
rdfs:comment
  • Galapagos NV is a Belgo-Dutch pharmaceutical research company which was founded in 1999. The company started as a joint venture between Crucell - a Leiden based biotech company - and Belgian Tibotec. Currently it has drugs under investigation against rheumatoid arthritis, crohn's disease, ulcerative colitis, psoriasis and systemic lupus erythematosus. The stocks are traded at Euronext Amsterdam and Euronext Brussels under ticker GLPG and at the U.S. OTC market under the ticker symbol GLPYY. The CEO is the Dutchman Onno van de Stolpe. The headquarters are located in Mechelen, Belgium. Also Galapagos holds branches in Leiden, Romainville (France) and Zagreb (Croatia).
sameAs
dct:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
foaf:name
  • Galapagos NV
foaf:homepage
geo:lat
geo:long
foaf:isPrimaryTopicOf
geo:geometry
  • POINT(4.4522223472595 51.055278778076)
prov:wasDerivedFrom
has abstract
  • Galapagos NV is a Belgo-Dutch pharmaceutical research company which was founded in 1999. The company started as a joint venture between Crucell - a Leiden based biotech company - and Belgian Tibotec. Currently it has drugs under investigation against rheumatoid arthritis, crohn's disease, ulcerative colitis, psoriasis and systemic lupus erythematosus. The stocks are traded at Euronext Amsterdam and Euronext Brussels under ticker GLPG and at the U.S. OTC market under the ticker symbol GLPYY. The CEO is the Dutchman Onno van de Stolpe. The headquarters are located in Mechelen, Belgium. Also Galapagos holds branches in Leiden, Romainville (France) and Zagreb (Croatia).
assets ($)
  • 1.11E8
equity ($)
  • 1.41E8
founding year
industry
internationally
key person
location
number of employees
operating income ($)
  • 1.52E8
product
revenue ($)
  • 1.6E8
type
georss:point
  • 51.055277777777775 4.452222222222222
http://purl.org/voc/vrank#hasRank
http://purl.org/li...ics/gold/hypernym
is sameAs of
is Link from a Wikipage to another Wikipage of
is Wikipage disambiguates of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git21 as of Mar 09 2019


Alternative Linked Data Documents: PivotViewer | iSPARQL | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3230 as of Dec 18 2018, on Linux (x86_64-generic-linux-glibc25), Single-Server Edition (61 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2019 OpenLink Software